DR. CHARLES N SOPARKAR, M.D., PH.D
Medical Practice at Kirby Dr, Houston, TX
License number
Texas J6247
Category
Medical Practice
Type
Legal Medicine
Address
Address
3730 Kirby Dr SUITE 900, Houston, TX 77098
Phone
(713) 795-0705
(713) 807-0630 (Fax)
(713) 807-0630 (Fax)
Personal information
See more information about CHARLES N SOPARKAR at radaris.comName
Address
Phone
2620 Pittsburgh St, Houston, TX 77005
2620 Pittsburgh St, Houston, TX 77005
3730 Kirby Dr, Houston, TX 77098
6655 Travis St, Houston, TX 77030
Professional information
See more information about CHARLES N SOPARKAR at trustoria.com
Dr. Charles S Soparkar - MD (Doctor of Medicine)
Dr. Charles S Soparkar - MD (Doctor of Medicine)
Hospitals:
Plastic Eye Surgery Association
3730 Kirby Dr SUITE 900, Houston 77098
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
Plastic Eye Surgery Association
3730 Kirby Dr SUITE 900, Houston 77098
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
3730 Kirby Dr SUITE 900, Houston 77098
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
Plastic Eye Surgery Association
3730 Kirby Dr SUITE 900, Houston 77098
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
Education:
Medical Schools
University of Massachusetts / Worcester Campus
University of Massachusetts / Worcester Campus
Oculoplastic Surgeon At Plastic Eye Surgery Associates, Pllc
Oculoplastic Surgeon At Plastic Eye Surgery Associates, Pllc
Position:
Oculoplastic Surgeon at Plastic Eye Surgery Associates, PLLC
Location:
Houston, Texas Area
Industry:
Medical Practice
Work:
Plastic Eye Surgery Associates, PLLC
-
Oculoplastic Surgeon
Education:
Oberlin College
B.A., Biology (Honors) University of Massachusetts Medical School
Ph.D., Molecular Biochemistry University of Massachusetts Medical School
M.D., Medical Sciences
B.A., Biology (Honors) University of Massachusetts Medical School
Ph.D., Molecular Biochemistry University of Massachusetts Medical School
M.D., Medical Sciences
Interests:
plastic and aesthetic surgery, oculoplastic surgery, molecular biochemistry, ocular pathology, ophthalmic oncology, and ocular and peri-ocular aging
Honor & Awards:
Fellowship status
American Society of Clinical Oncology
(1 of only 2 ophthalmologists in the world)
1996
Fellowship status
American College of Surgeons
2002
Colonel
Honorary Commission
Extended by Kentucky Governor Patton and National Commanding General, James Molley For Educational and Research Services
2003
Fellowship status
American Society of Ophthalmic Plastic and Reconstructive Surgeons 2004
“Super Doctor in Texas”
Chosen annually by Texas Monthly Magazine
2005 – Current
America’s Top Doctors for Cancer
Chosen annually by Castle Connolly Medical
2007 -- Current
Fellowship status
American Academy of Cosmetic Surgery
“Outstanding Patients’ Choice Physician”
Selected annually from among 720,000 physicians
2008 – Current
“America’s Top Doctors”
Chosen annually by Castle Connolly Medical
2008 – Current
“Top Doctor in Houston”
Selected annually
H Texas Magazine
2008 - Current
Charles Sidhartha Soparkar, Houston TX
Charles Sidhartha Soparkar, Houston TX
Specialties:
Ophthalmology
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030 Plastic Eye Surgery Associates
6560 Fannin St, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030 Plastic Eye Surgery Associates
6560 Fannin St, Houston, TX 77030
Education:
University of Massachusetts (1990)
Compositions And Methods For Enhancing Metal Ion Dependent Drug Therapies
Compositions And Methods For Enhancing Metal Ion Dependent Drug Therapies
US Patent:
2010033, Dec 30, 2010
Filed:
Jun 23, 2010
Appl. No.:
12/821370
Inventors:
Charles N.S. Soparkar - Houston TX, US
International Classification:
A61K 33/30, A61P 17/02, A61P 37/00, A61P 15/10, A61K 38/46, A61K 31/315, A61K 38/16, A61K 9/127
US Classification:
424450, 424 946, 424641, 514494, 514 177
Abstract:
Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.
Compositions And Methods For Enhancing Metal Ion Dependent Drug Therapies
Compositions And Methods For Enhancing Metal Ion Dependent Drug Therapies
US Patent:
2014005, Feb 27, 2014
Filed:
Oct 30, 2013
Appl. No.:
14/067654
Inventors:
Charles N.S. Soparkar - Houston TX, US
Assignee:
CNSS IP Holdings, Inc. - Houston TX
International Classification:
A61K 33/30, A61K 38/46
US Classification:
424 946, 556118, 556 40
Abstract:
Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.